rfhg_44279.1

Basic information about the TSS

---

TSS ID: rfhg_44279.1 Species: human Chr: chr3		Start: 42600701 End: 42600711 Strand: -
Source datasets	ENCODE
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000450981.5:177 GeneID: 9117 HGNC/MGI_ID: HGNC:16828 UniProt_ID: C9J2R1 Nearer transcript ids and distances: NM_001201572.2:-367 ENST00000417572.5:-369 view more...

Gene_name: SEC22 homolog C, vesicle trafficking protein Gene_symbol: SEC22C Gene_synonyms: MGC13261 MGC5373 Gene_source: HGNC:16828

TATA-Box annotation

---

Distance to TSS:	20
Nearest PromoterID:	NM_001349124
Entrez ID:	4820
Nearest Unigene:	Hs.529509
Nearest Refseq:	NM_005385
Nearest Ensembl:	ENSG00000114857
Gene Name:	SEC22 homolog C, vesicle trafficking protein
Gene Alias:	p104
Gene Type:	protein-coding
CpG%:	0.200000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SEC22C p2@SEC22C p3@SEC22C p6@SEC22C p7@SEC22C
Sample		p1@SEC22C	p2@SEC22C	p3@SEC22C	p6@SEC22C	p7@SEC22C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.03	7.40	0.58	0.19	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.54	6.68	0.81	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.15	4.82	0.19	0.39	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.89	6.03	1.04	0.42	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.42	6.75	0.45	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.05	6.78	0.78	0.19	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.78	10.02	0.44	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	19.62	6.78	0.48	0.00	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.38	8.12	0.21	0.00	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.08	12.75	1.16	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.64	15.36	0.81	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.08	14.23	0.00	0.41	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	35.30	2.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.95	1.35	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.42	3.51	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.64	1.76	0.25	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.81	1.97	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.31	2.11	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.09	2.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.41	1.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.14	3.28	0.17	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.30	2.46	0.26	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.12	1.94	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	30.18	2.06	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.17	1.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	2.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	35.60	2.59	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	24.71	3.23	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.14	3.08	0.18	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.21	2.30	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.81	2.93	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.91	1.27	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.28	1.32	0.16	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.73	3.37	0.00	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.89	2.30	0.19	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.59	2.86	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.99	1.81	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	31.60	0.81	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	25.69	2.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.11	2.35	0.24	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	25.33	1.90	0.00	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	31.84	2.32	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.29	2.80	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.92	1.41	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	36.53	2.79	0.23	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.55	3.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.06	2.98	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.58	3.83	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.04	2.83	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	45.70	2.46	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.81	4.00	0.22	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	38.32	2.48	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	43.74	1.33	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	12.58	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	0.46	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	47.97	3.89	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.82	2.25	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	34.89	2.83	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	3.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	30.28	3.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.07	5.57	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.20	2.38	0.00	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	55.24	3.57	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.44	2.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.78	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	58.02	2.48	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	54.89	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	57.30	1.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	56.30	1.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	52.28	3.06	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	43.24	2.06	2.38	3.33	0.32
Adipocyte - breast, donor2	11327-117E4	31.60	1.28	0.96	1.60	0.48
Adipocyte - omental, donor1	11473-119C6	31.68	1.53	2.04	3.31	0.13
Adipocyte - omental, donor2	11474-119C7	44.10	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	45.55	1.00	0.00	2.34	1.34
Adipocyte - perirenal, donor1	11476-119C9	51.04	1.28	1.28	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	24.84	1.35	1.35	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	19.12	0.52	0.70	1.04	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	32.07	1.76	1.17	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	25.48	2.57	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	31.50	1.39	1.12	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	42.91	1.18	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	27.11	2.09	1.05	0.80	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	28.08	1.61	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	28.79	1.60	1.07	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	22.26	0.56	0.00	1.67	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	24.54	1.66	0.83	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	18.34	0.75	0.75	1.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	26.51	3.27	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	20.70	1.52	0.61	1.22	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	31.16	3.09	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	19.36	3.59	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.02	3.06	1.80	0.00	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.54	1.85	1.44	0.62	0.41
Anulus Pulposus Cell, donor1	11248-116E6	37.76	1.72	0.34	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	27.43	0.49	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	0.45	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.97	0.43	1.30	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	1.49	0.90	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	3.30	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	19.42	1.46	1.46	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	2.38	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.46	0.38	0.75	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	0.00	1.45	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	0.00	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.94	0.66	0.16	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	1.36	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.52	0.90	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	14.47	1.07	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.49	1.32	0.76	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.12	0.80	0.53	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.58	1.00	1.49	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.47	1.72	0.17	1.20	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.99	1.46	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	1.52	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	2.85	1.14	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	21.81	0.64	0.21	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.10	1.29	0.26	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.71	0.47	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.90	0.32	1.29	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	26.40	1.43	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.38	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.97	1.20	0.00	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	1.53	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.10	2.04	0.25	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.01	0.43	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.78	1.48	0.85	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.40	0.29	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.82	1.19	0.68	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	0.00	0.00	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.37	0.86	0.21	1.50	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.86	4.81	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	0.73	2.19	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	21.15	0.69	0.23	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.41	1.53	0.51	1.27	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.44	0.83	1.24	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.05	0.61	0.31	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.34	0.96	0.48	2.39	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.63	1.33	0.67	0.89	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	0.00	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.17	1.11	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.27	0.79	0.26	1.59	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.81	1.82	0.00	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	54.65	2.09	0.61	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	38.85	2.40	0.51	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	29.78	1.05	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	57.87	2.09	0.70	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.49	4.04	0.32	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	55.49	2.09	0.30	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	27.75	3.67	0.80	0.23	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.19	4.13	1.50	0.13	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	22.76	3.98	0.91	0.11	1.02
Basophils, donor1	12241-129G9	9.42	0.78	10.46	0.00	1.31
Basophils, donor2	12242-129H1	29.95	3.25	14.07	0.36	3.97
Basophils, donor3	12243-129H2	10.00	0.44	5.88	0.00	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	17.03	1.94	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	25.60	1.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.36	1.26	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	25.58	4.16	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	36.62	2.99	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	21.05	1.44	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.87	9.17	0.72	0.00	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.09	6.52	0.23	0.00	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.90	0.96	1.60	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	2.25	3.38	0.00	2.25
CD14+ Monocytes, donor2	11305-117B9	12.25	0.37	4.64	0.00	1.11
CD14+ Monocytes, donor3	11381-118B4	12.29	0.88	4.83	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.99	0.85	2.55	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.42	0.76	6.82	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	50.63	1.31	2.63	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	20.67	1.45	5.06	0.58	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	0.91	2.72	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	14.45	0.47	2.61	0.24	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.89	0.33	5.02	0.00	2.18
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.35	0.00	3.31	0.00	1.93
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.42	0.50	7.44	0.00	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.05	0.59	1.96	0.00	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.72	0.53	1.42	0.00	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.58	0.22	4.35	0.22	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.66	0.00	5.15	0.23	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	0.00	2.64	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	0.00	3.33	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.90	0.59	3.27	0.00	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.98	0.40	4.19	0.00	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.32	2.71	4.79	0.00	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.69	0.00	4.58	0.23	2.75
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.37	0.45	5.88	0.00	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.00	2.62	0.00	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	11.84	0.54	3.50	0.27	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.51	0.35	2.44	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.68	0.84	3.37	0.00	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.33	0.00	3.86	0.00	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.82	0.35	2.47	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.19	0.00	3.07	0.00	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.24	0.17	3.66	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.58	0.74	5.58	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.64	1.08	5.39	0.22	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.96	0.82	2.87	0.41	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.72	0.23	1.62	0.00	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.18	0.23	2.78	0.00	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	16.13	0.87	4.80	0.65	1.96
CD14+CD16+ Monocytes, donor2	11801-124D1	13.17	0.00	8.08	0.00	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	15.16	0.43	3.68	0.22	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	30.99	0.47	2.65	0.00	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	23.23	0.52	2.27	0.00	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	24.08	0.22	0.89	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	6.38	0.77	8.17	0.77	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	7.25	0.22	9.22	0.66	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	11.37	0.63	7.58	0.42	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	33.90	2.71	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	40.39	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	35.18	1.07	2.67	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	36.45	2.68	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	37.90	2.81	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.92	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	29.00	2.64	3.95	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	30.41	3.29	14.79	0.00	4.11
CD19+ B Cells, donor2	11624-122B4	24.66	1.45	17.41	0.00	2.90
CD19+ B Cells, donor3	11705-123B4	24.74	2.02	14.14	0.00	7.57
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	15.35	3.64	88.08	0.00	10.10
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.38	3.20	78.30	0.00	9.99
CD34+ Progenitors, donor1	11545-120B6	20.08	1.00	4.02	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	19.66	2.25	9.55	0.56	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	20.67	0.75	3.38	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.22	1.35	5.41	0.68	1.13
CD4+ T Cells, donor1	11225-116C1	41.78	4.28	22.49	0.36	3.57
CD4+ T Cells, donor2	11306-117C1	53.89	1.84	18.98	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	43.92	6.71	15.25	0.00	4.27
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	31.90	2.81	4.34	0.00	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	35.26	2.02	3.14	0.00	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	37.08	3.74	2.30	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.45	4.74	12.33	0.00	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	57.59	3.51	19.67	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	0.00	13.18	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.95	3.03	5.20	0.00	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.81	4.24	4.91	0.17	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	33.53	4.19	4.51	0.00	1.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	31.38	4.93	9.41	0.00	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	37.73	4.54	10.83	0.00	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	44.44	6.60	11.44	0.00	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	51.02	3.37	5.90	0.42	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.88	3.74	4.16	0.00	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	42.43	3.01	3.34	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.40	3.81	9.79	0.00	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	55.74	2.68	6.97	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	1.79	14.35	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	46.17	5.38	6.68	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	44.84	4.55	4.98	0.22	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.33	3.57	3.57	0.21	2.10
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	46.52	7.08	12.64	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.69	4.77	16.46	0.43	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.94	4.79	10.90	0.00	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	57.90	2.47	1.98	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	59.08	6.46	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	62.81	5.58	2.79	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	72.83	3.60	1.94	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	68.95	3.93	1.47	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	66.22	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	54.08	6.80	2.86	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	63.71	8.31	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	33.07	5.89	17.35	0.00	5.57
CD8+ T Cells, donor2	11307-117C2	31.54	5.26	10.89	0.00	3.00
CD8+ T Cells, donor3	11383-118B6	29.79	4.80	14.14	0.00	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	29.13	2.29	2.29	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.48	2.64	4.31	0.00	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.43	2.74	1.37	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.91	2.70	3.60	0.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.40	1.92	4.32	0.24	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.06	3.18	3.64	0.00	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.68	2.82	5.00	0.22	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.90	2.63	2.90	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.86	3.28	1.64	0.23	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	34.72	3.02	1.21	0.00	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	2.61	2.03	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.50	2.93	2.66	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	6.57	1.75	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.51	4.10	3.19	0.91	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	5.97	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	25.57	1.80	3.96	0.72	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	27.05	2.30	2.59	0.00	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.92	2.36	1.89	0.47	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	0.95	2.85	0.32	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.07	3.69	3.08	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.04	3.21	3.85	0.32	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	33.27	3.44	1.53	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	30.74	4.34	3.15	0.00	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	2.27	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.10	1.61	2.41	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	38.47	5.60	2.80	4.20	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	43.08	6.01	3.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	21.93	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	26.19	0.49	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	24.31	1.37	0.84	0.63	0.00
Chondrocyte - de diff, donor1	11261-116G1	67.95	2.43	2.43	2.08	0.69
Chondrocyte - de diff, donor2	11338-117F6	37.67	2.13	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	37.77	1.71	0.34	0.34	0.11
Chondrocyte - re diff, donor2	11339-117F7	40.29	3.58	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	29.52	2.02	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	42.23	2.30	0.11	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	31.00	1.71	0.00	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	30.62	3.45	0.09	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	53.46	3.85	1.19	1.10	0.46
Corneal Epithelial Cells, donor1	11526-119I5	27.45	1.98	0.22	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	21.61	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	28.63	1.79	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.59	0.50	6.77	0.17	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.07	1.58	6.31	0.00	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	20.95	1.62	4.64	0.43	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.11	0.34	3.07	0.00	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.73	0.00	1.31	0.65	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	34.84	0.00	1.45	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	30.19	1.33	0.83	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	28.28	2.55	0.85	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	33.42	3.15	0.79	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	24.72	2.62	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	29.65	2.35	0.24	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	25.24	2.63	0.35	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	37.90	4.21	1.33	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	37.73	2.13	3.04	1.83	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.65	1.41	0.85	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	43.98	2.67	0.59	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	35.41	2.60	0.52	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	28.22	2.98	0.28	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	54.82	2.00	0.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.21	5.34	0.99	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.41	4.13	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	39.45	4.15	0.61	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	25.03	1.14	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	22.35	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	34.54	2.67	0.31	0.16	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	11.55	4.95	14.85	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	0.00	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.19	2.93	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	4.16	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	46.39	2.05	1.64	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.31	1.53	0.88	0.99	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	48.97	2.93	1.63	0.11	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.90	2.67	1.58	0.61	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	16.92	0.96	1.09	0.68	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	24.05	0.84	1.16	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	1.05	0.79	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.90	1.66	1.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	26.76	2.72	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	19.71	0.00	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.08	2.21	0.63	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	28.49	0.61	2.42	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	44.42	2.54	0.63	0.00	0.38
Fibroblast - Cardiac, donor6	11460-119B2	38.96	3.18	0.61	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.50	1.07	0.54	0.80	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.32	1.29	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	58.12	2.08	0.23	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	40.37	2.20	1.19	1.53	0.68
Fibroblast - Dermal, donor1	11269-116G9	23.71	1.41	0.70	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	22.64	0.94	0.00	0.47	1.42
Fibroblast - Dermal, donor3	11418-118F5	30.58	0.85	0.97	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	58.22	2.37	0.45	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	60.19	3.31	0.70	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	61.23	1.62	0.00	0.00	0.32
Fibroblast - Gingival, donor1	11237-116D4	43.31	1.87	1.25	0.62	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.68	0.79	0.00	1.83	0.00
Fibroblast - Gingival, donor2	11318-117D4	45.99	2.37	0.53	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	46.51	1.45	1.74	0.58	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	2.08	1.04	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.19	1.23	0.35	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.08	2.96	0.47	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	53.01	1.49	0.81	0.81	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.59	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	53.82	2.05	1.46	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.86	1.50	0.82	1.91	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	55.94	1.97	1.43	1.43	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	43.29	0.59	0.59	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	16.31	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	50.73	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	30.60	2.11	1.48	0.21	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	68.31	3.33	0.00	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	50.35	1.40	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	19.87	0.84	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	55.62	2.03	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	55.92	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	55.48	2.52	0.58	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	52.03	1.67	0.46	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	42.53	2.75	1.22	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	40.45	0.76	0.76	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.48	0.81	0.81	1.35	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.44	0.93	0.58	0.58	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.71	3.09	1.66	0.44	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	51.00	1.02	1.22	1.22	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	1.58	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.36	0.20	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.55	1.42	0.89	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.70	0.79	0.59	1.58	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.08	1.81	0.90	1.81	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.56	0.97	0.32	1.19	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	19.49	0.76	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	40.36	0.82	0.33	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.27	1.20	0.60	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	47.82	1.21	0.40	1.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.13	0.30	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.51	1.16	0.33	1.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	46.16	1.03	1.54	2.05	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.03	0.66	0.33	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.04	2.02	0.75	1.38	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	36.27	2.02	0.51	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.58	1.10	0.16	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	0.87	2.61	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.67	3.29	2.77	0.17	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.79	7.81	0.52	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.73	5.37	0.77	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.20	6.12	0.00	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	5.74	0.64	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	54.77	15.69	0.00	1.14	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.29	2.21	0.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	43.15	4.11	0.00	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	50.92	11.49	0.00	0.40	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	34.89	2.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.09	7.50	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	44.66	12.82	0.00	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	19.93	4.52	0.28	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.84	3.45	0.00	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	15.58	3.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.35	1.36	0.00	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.95	1.80	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.01	3.05	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	20.76	3.42	0.23	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.44	2.87	0.12	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.45	2.84	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.93	1.48	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.90	1.43	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.33	2.01	0.67	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.41	2.82	0.20	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	22.56	1.87	0.17	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	26.78	2.48	0.62	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.01	2.08	0.62	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.45	2.22	0.51	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	22.02	1.44	0.77	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.37	2.25	0.67	0.42	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.99	1.23	0.41	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	32.39	3.30	1.03	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.71	2.65	1.15	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.68	3.17	0.33	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.79	1.76	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.29	1.97	1.84	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.91	3.08	0.97	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	40.41	1.60	0.64	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.07	1.90	1.42	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.47	2.21	1.27	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	1.82	1.52	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	26.13	3.03	1.05	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.66	1.76	1.76	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.95	1.68	1.68	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.02	1.76	3.15	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.29	4.01	2.41	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.83	2.14	2.30	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.45	2.59	2.46	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.67	4.61	1.63	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.55	1.84	1.66	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.68	1.97	2.41	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	1.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.02	2.77	1.06	0.26	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	29.46	2.02	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.84	1.78	2.29	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	29.26	4.98	0.20	1.19	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.80	3.54	0.00	0.46	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.44	3.89	0.00	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.35	9.70	0.00	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.39	8.19	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.97	10.15	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	12.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.05	4.64	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	8.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	5.22	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.20	7.49	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.77	6.18	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.05	4.19	0.28	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	24.84	5.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	28.52	6.71	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.81	4.13	0.32	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.13	3.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	8.35	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.07	3.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	21.01	1.78	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	29.41	6.63	0.00	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.50	3.91	0.00	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.45	3.84	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.43	3.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	37.46	4.68	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	38.91	3.85	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.09	3.42	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.86	3.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.62	3.02	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.06	6.10	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.90	3.99	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.60	3.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	5.90	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.09	1.75	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.06	3.51	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	2.54	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.28	3.58	1.19	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.10	2.91	0.97	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.96	0.42	0.00	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	0.00	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.64	0.95	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.39	0.42	1.25	0.42	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.03	4.87	2.67	0.70	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.61	3.38	3.38	0.34	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	20.25	2.50	2.73	0.68	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.60	3.94	2.51	0.77	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.19	4.94	2.58	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.21	4.52	2.80	0.00	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.82	4.11	4.11	0.37	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.95	4.80	4.12	0.17	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.49	4.81	3.20	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	43.65	6.16	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	26.40	1.30	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.74	2.47	1.76	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	28.15	2.97	2.10	0.17	0.35
Hepatocyte, donor1	11523-119I2	14.53	3.63	2.42	0.00	1.21
Hepatocyte, donor2	11603-120I1	21.55	5.39	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	22.09	2.45	1.23	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.16	0.65	2.61	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.05	6.12	2.97	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.29	2.47	0.00	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	6.92	2.77	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	3.25	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	1.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	2.65	1.32	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	4.43	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.90	5.04	3.78	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	4.52	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	33.81	4.83	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	4.07	7.33	0.00	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	0.84	2.52	0.00	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	17.68	3.21	4.82	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.93	1.85	3.69	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	5.19	3.78	0.00	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	2.72	1.81	0.91	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	5.38	4.30	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	6.35	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	3.19	3.83	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	2.14	2.14	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.26	3.09	2.16	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.30	6.95	2.78	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	11.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	11.34	0.87	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	4.50	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	19.20	5.33	3.20	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	2.77	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	10.12	5.52	1.84	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	6.05	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	21.62	3.59	1.14	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	19.33	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	46.19	4.16	0.66	0.38	0.00
Keratinocyte - oral, donor1	11251-116E9	42.46	2.95	0.45	0.11	0.00
Keratocytes, donor1	11527-119I6	40.57	2.41	2.06	0.00	0.34
Keratocytes, donor2	11607-120I5	44.53	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	25.89	0.40	0.40	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	0.00	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	36.91	1.04	0.35	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	17.86	1.21	0.30	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.45	1.90	1.19	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.14	1.95	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.62	4.72	0.94	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	1.61	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.31	0.32	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.54	4.85	0.54	0.65	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.73	2.46	0.41	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	30.09	3.03	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.57	2.96	0.70	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	31.64	1.98	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.44	2.71	0.39	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.92	3.33	0.74	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.87	1.39	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	28.62	2.39	0.95	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.29	3.16	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	30.18	2.77	0.62	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	21.82	2.81	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.30	3.29	1.28	0.73	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.28	4.28	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	20.50	0.88	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.64	2.49	1.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.07	0.97	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.39	1.62	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.73	3.63	1.67	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.92	0.52	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.73	2.30	0.63	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	28.57	3.46	1.65	0.75	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	33.02	2.75	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.11	3.01	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.46	3.50	1.27	0.85	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.79	1.65	0.33	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.39	3.59	1.36	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.25	2.96	0.37	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.44	2.96	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.30	3.16	0.96	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	2.25	0.64	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	36.82	1.22	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	30.93	4.20	1.12	0.56	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.33	3.56	1.78	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	27.63	1.94	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.05	1.87	0.78	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	31.51	3.22	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.11	1.63	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.19	3.30	0.94	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	32.79	2.48	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.59	1.54	0.51	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.24	3.58	0.60	1.19	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6.35	0.42	1.69	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	4.22	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	2.80	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.73	1.55	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.92	1.36	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.40	2.33	1.16	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	4.05	1.35	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.81	1.76	1.35	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	1.03	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.76	1.76	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	10.70	2.04	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.87	1.60	1.33	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6.05	1.70	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	2.45	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5.71	3.26	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.83	2.08	1.25	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.37	2.52	1.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	3.09	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.39	0.29	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	2.99	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	1.11	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	2.12	2.47	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	1.48	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.76	1.92	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.06	3.40	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	3.28	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	1.36	1.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	2.87	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	1.49	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.29	1.86	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	1.29	0.43	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	0.86	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.00	2.00	1.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.05	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	0.71	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	1.37	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	2.15	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	1.35	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.00	2.59	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.20	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	2.91	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.90	1.53	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.87	0.49	1.48	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	1.88	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.57	4.02	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.56	0.90	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.68	2.67	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	4.69	1.96	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	2.64	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.30	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.31	0.88	1.31	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.18	0.56	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.62	0.88	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.17	1.54	1.16	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.61	2.53	2.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	0.80	1.59	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	2.43	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	9.68	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.84	1.14	1.52	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	1.55	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.24	1.27	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	2.13	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	1.15	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	2.06	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	1.70	1.13	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	2.50	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	0.78	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	2.09	0.84	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	5.58	2.32	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	7.36	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.88	0.00	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.27	1.62	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	0.89	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.41	2.85	1.14	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.07	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.11	1.09	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.24	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.10	1.30	0.26	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	43.53	0.91	6.61	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	29.73	2.20	10.83	0.00	1.47
Macrophage - monocyte derived, donor3	11389-118C3	38.01	1.84	5.37	0.00	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.33	6.37	3.19	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	50.39	4.75	1.90	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	44.75	6.81	1.11	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	40.16	6.68	0.90	1.40	1.00
Mammary Epithelial Cell, donor2	11350-117G9	42.27	3.19	1.16	0.00	0.87
Mammary Epithelial Cell, donor3	11422-118F9	22.95	3.49	0.75	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	27.80	2.03	35.93	0.00	3.39
Mast cell, donor1	11563-120D6	37.85	1.51	41.74	0.22	3.68
Mast cell, donor2	11565-120D8	43.09	0.89	27.64	0.00	2.08
Mast cell, donor3	11566-120D9	44.12	2.03	33.32	0.45	3.60
Mast cell, donor4	11567-120E1	45.21	0.71	35.46	0.00	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	44.47	2.00	21.29	0.00	2.11
Mast cell, expanded and stimulated, donor8	11942-126A7	43.19	0.58	15.18	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	57.93	0.69	33.38	0.23	2.87
Mast cell, expanded, donor8	11941-126A6	37.49	1.00	28.12	0.33	3.85
Melanocyte - dark, donor1	11502-119F8	45.07	3.58	0.90	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	18.34	3.11	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	45.35	2.61	15.79	0.22	1.59
Melanocyte - light, donor1	11274-116H5	23.74	0.94	2.82	0.00	0.47
Melanocyte - light, donor2	11351-117H1	21.84	1.36	4.09	1.36	0.68
Melanocyte - light, donor3	11423-118G1	12.14	0.00	2.60	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.86	1.56	5.00	0.10	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	41.69	5.11	8.61	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	35.36	1.87	8.30	0.00	0.27
Meningeal Cells, donor1	11493-119E8	66.74	1.61	0.62	0.00	0.00
Meningeal Cells, donor2	11573-120E7	40.05	4.84	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	46.37	3.75	0.82	0.08	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	34.79	2.28	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	22.44	1.61	2.92	1.91	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	48.80	1.44	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.99	1.48	0.21	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.72	2.01	1.51	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	37.36	2.42	0.88	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	35.80	2.19	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.78	2.66	0.00	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.36	0.28	0.28	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.10	1.49	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.58	2.11	0.39	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.91	0.59	1.48	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.30	2.56	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	48.56	2.48	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	40.97	2.50	1.25	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	34.11	2.18	0.73	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	32.35	2.39	1.06	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	23.52	0.50	0.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	28.04	2.67	0.51	0.43	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	2.70	9.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	37.68	4.43	12.07	0.74	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	33.27	2.36	12.37	0.29	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.23	0.93	7.75	0.31	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.63	2.28	12.03	0.00	2.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	4.63	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.53	0.75	7.51	0.25	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	1.40	11.17	0.00	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.65	1.22	8.54	0.20	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.70	1.58	9.50	0.40	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	27.43	0.00	11.50	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	2.28	12.92	0.00	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.07	1.70	9.13	0.00	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	25.78	0.00	6.45	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.06	1.79	5.37	0.00	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	0.00	3.35	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	27.60	3.01	10.29	0.00	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.77	1.19	6.18	0.71	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	25.43	3.32	3.87	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.18	1.84	8.06	1.15	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.30	2.73	8.83	0.21	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	23.03	0.41	5.10	0.00	1.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.03	1.72	7.94	0.00	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.45	1.33	3.56	0.22	1.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.56	0.88	8.10	0.22	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.81	3.55	4.56	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.28	0.27	4.89	0.00	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.23	2.94	8.23	0.59	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	1.09	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.55	0.48	6.73	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.01	0.40	8.00	0.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	34.28	0.00	5.48	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.52	1.00	6.51	0.50	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	2.19	9.63	0.00	3.50
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	1.10	4.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	1.28	1.92	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	25.54	1.49	6.69	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	17.40	0.70	3.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.91	1.37	4.79	0.00	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	0.88	2.19	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.62	1.07	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	29.74	2.24	6.17	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.52	3.33	2.08	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	2.33	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.51	0.60	2.41	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.04	0.83	6.26	0.00	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	0.00	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.63	1.71	2.85	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	16.17	0.83	2.49	0.14	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	33.95	0.78	3.63	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.74	1.29	3.43	0.43	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.82	0.53	0.80	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.92	3.29	6.59	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.67	0.57	1.55	0.14	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	32.17	0.64	2.55	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.43	1.55	5.97	0.22	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.41	0.76	2.28	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	33.24	2.27	2.84	0.00	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	34.17	0.98	5.65	0.00	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	0.00	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.40	0.88	2.06	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.62	2.02	6.63	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	31.32	0.82	3.71	0.41	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	32.76	3.57	1.79	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	57.03	0.00	10.69	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	46.99	0.66	6.57	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	46.29	3.16	4.21	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.57	0.20	8.70	0.20	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	74.51	1.86	13.04	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.94	0.38	8.26	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.21	2.66	9.59	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	39.70	0.45	4.86	0.11	1.70
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	34.63	1.47	8.84	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	46.17	0.73	3.30	0.00	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	1.56	4.67	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	29.93	0.00	8.02	0.00	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	3.86	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	0.00	7.07	0.00	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.95	2.11	5.48	0.00	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	1.36	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	0.00	1.91	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	0.00	8.10	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	30.21	1.51	4.53	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	13.05	32.62	6.52	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	4.75	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.53	1.51	0.65	2.37	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.17	2.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	2.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.99	3.76	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.96	3.61	0.57	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	32.64	2.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	1.84	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	40.18	2.09	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	56.71	8.60	1.63	0.93	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.89	1.35	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.53	1.68	0.84	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	2.48	0.99	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.10	0.81	0.27	1.08	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.38	2.49	0.45	1.36	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	39.52	2.61	0.16	0.98	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.61	1.46	0.18	1.46	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.40	0.53	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.61	2.40	1.20	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.69	1.97	0.00	1.64	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	29.11	1.63	0.33	0.98	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	26.99	0.88	0.35	0.88	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	31.65	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.32	2.30	1.84	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	37.92	0.64	1.29	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.52	2.41	0.69	1.72	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	2.53	0.00	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.07	0.89	0.22	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	26.67	2.54	0.00	2.54	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.99	1.19	1.19	0.95	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	46.36	1.72	0.86	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	38.32	1.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.19	1.59	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	0.00	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	46.16	1.51	0.00	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.46	2.61	0.33	1.63	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	28.76	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	2.65	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	36.57	0.66	1.33	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	54.07	0.99	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.16	2.30	0.38	1.91	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.11	1.21	0.00	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.40	1.33	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.12	1.83	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	36.19	1.89	0.31	1.26	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	39.34	1.51	0.30	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	34.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.45	2.36	1.74	1.37	0.75
Myoblast, donor2	11322-117D8	25.51	1.34	0.58	0.19	0.19
Myoblast, donor3	11398-118D3	37.50	1.18	0.50	0.34	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	33.27	7.15	1.90	0.15	0.88
Natural Killer Cells, donor1	11230-116C6	32.29	5.23	16.61	0.00	2.46
Natural Killer Cells, donor2	11311-117C6	30.46	3.62	12.67	0.30	2.71
Natural Killer Cells, donor3	11387-118C1	25.95	3.13	12.52	0.18	4.79
Neural stem cells, donor1	11275-116H6	43.55	0.73	0.00	1.09	0.36
Neural stem cells, donor2	11352-117H2	40.44	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	55.76	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	51.08	1.54	0.22	0.00	0.22
Neurons, donor3	11655-122E8	64.13	4.93	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	8.35	0.00	3.71	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	7.33	1.83	6.11	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	32.30	2.14	0.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	25.07	1.30	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	29.48	0.60	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	37.17	1.51	0.41	2.06	0.14
Olfactory epithelial cells, donor2	11934-125I8	40.09	1.30	1.01	1.74	0.00
Olfactory epithelial cells, donor3	11935-125I9	35.98	2.38	0.57	0.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	41.49	1.75	0.97	0.97	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	32.50	2.41	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	19.99	0.43	2.13	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	25.15	1.14	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	23.59	1.24	3.72	0.00	0.62
Osteoblast, donor1	11277-116H8	21.50	0.98	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	21.07	0.70	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	26.48	1.96	0.36	1.42	0.18
Pancreatic stromal cells, donor1	11249-116E7	34.71	1.18	1.94	0.42	0.76
Pericytes, donor1	11491-119E6	30.93	0.45	0.45	0.45	0.00
Pericytes, donor2	11571-120E5	25.35	0.00	0.45	0.45	0.23
Pericytes, donor3	11652-122E5	31.94	1.42	0.41	0.81	0.00
Perineurial Cells, donor1	11499-119F5	34.25	1.47	0.00	0.00	0.23
Perineurial Cells, donor2	11579-120F4	24.84	1.29	0.74	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.83	1.59	9.24	0.00	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.57	1.22	7.59	0.00	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.41	1.16	4.92	0.00	1.16
Placental Epithelial Cells, donor1	11278-116H9	17.70	3.11	2.39	0.48	0.72
Placental Epithelial Cells, donor2	11355-117H5	25.50	1.11	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	16.88	1.37	0.39	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	40.82	1.27	0.32	3.80	0.00
Preadipocyte - breast, donor1	11467-119B9	37.71	2.81	1.69	1.69	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	17.36	0.91	0.13	0.65	0.00
Preadipocyte - breast, donor2	11328-117E5	34.22	1.13	0.90	1.58	0.00
Preadipocyte - omental, donor1	11468-119C1	35.80	2.02	1.49	0.96	0.64
Preadipocyte - omental, donor2	11329-117E6	47.58	3.06	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	31.23	2.15	0.86	1.86	0.29
Preadipocyte - perirenal, donor1	11469-119C2	36.42	0.98	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.19	1.54	0.61	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	43.92	1.95	1.59	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	36.10	2.55	1.02	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	43.87	1.49	1.02	1.02	0.28
Preadipocyte - visceral, donor2	11357-117H7	32.21	0.46	0.46	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	39.92	2.61	0.94	1.25	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.93	5.28	0.60	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	21.80	4.20	0.54	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	14.76	1.78	0.43	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	34.40	3.53	1.14	1.14	0.57
Prostate Stromal Cells, donor2	11332-117E9	37.11	2.69	0.54	0.90	0.72
Prostate Stromal Cells, donor3	11405-118E1	24.61	1.46	0.83	1.25	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.83	2.19	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	34.31	1.25	0.14	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	26.88	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.88	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	30.91	1.38	0.11	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	40.85	4.09	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.08	3.77	0.40	0.00	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.31	2.89	0.44	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	2.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	32.57	1.98	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	32.60	2.51	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	19.42	1.94	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.63	3.76	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.52	2.53	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.29	3.09	0.19	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.04	3.11	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.89	1.99	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	20.58	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.09	1.25	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.72	2.81	1.47	0.40	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	36.63	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	1.10	1.65	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	1.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	34.98	2.47	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.93	2.68	0.50	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.67	2.12	0.45	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	29.65	3.60	0.25	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.50	2.21	0.23	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.44	2.31	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	22.32	2.19	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.26	2.72	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.60	1.79	0.36	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.99	1.29	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.18	1.82	0.32	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.43	2.43	0.89	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.75	3.25	0.00	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.36	2.61	0.09	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.07	1.32	0.19	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.20	2.12	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.08	2.04	0.10	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	27.31	1.91	0.38	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.48	1.39	0.21	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.39	2.52	0.00	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.07	2.39	0.51	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	27.53	3.10	0.36	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	24.04	1.96	0.49	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.92	1.34	0.13	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	2.83	0.00	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.21	2.38	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	30.40	2.34	0.23	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.33	1.24	0.41	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.42	1.77	0.44	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	23.19	3.13	0.21	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.72	3.10	0.67	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	27.93	3.07	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.91	2.89	0.39	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.57	2.41	0.52	0.86	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.12	3.43	0.14	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	30.37	2.63	0.16	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.08	1.70	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.11	2.96	0.30	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.92	2.67	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.56	1.24	0.14	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.00	2.86	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.62	3.02	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.94	3.01	0.28	0.38	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.09	2.45	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.22	1.81	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	31.58	1.84	0.37	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.76	5.53	0.58	0.29	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	37.72	2.43	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.33	2.41	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.76	3.62	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	38.04	5.39	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.71	1.77	0.24	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.14	3.63	0.85	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.85	0.00	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	40.81	1.50	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	47.63	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	36.81	2.41	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	41.08	3.29	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	23.90	5.51	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	24.12	1.86	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	43.07	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.39	0.97	0.00	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.01	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	41.80	0.84	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	48.70	2.67	1.10	0.94	0.00
Skeletal Muscle Cells, donor5	11455-119A6	43.26	2.82	0.30	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	49.25	2.46	0.46	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.26	2.14	0.25	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.39	1.85	0.00	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	43.85	3.47	0.99	0.00	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.35	1.01	0.17	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	38.36	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.33	1.79	0.14	0.83	0.14
Skin - palm, donor1	10286-104F7	45.66	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.53	5.91	0.86	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	52.35	10.63	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.04	4.28	0.65	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	36.28	5.42	0.70	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	20.25	6.47	0.42	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	40.60	4.02	0.63	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	16.56	3.67	0.52	0.07	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	31.17	2.47	0.00	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.57	1.56	0.44	0.67	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.80	0.66	0.22	0.66	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.35	0.39	0.39	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	29.36	0.77	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.37	0.93	0.13	1.20	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.27	1.77	0.89	1.55	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.67	2.18	0.26	3.07	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	36.14	1.95	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.51	2.36	1.18	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.78	2.28	0.85	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	26.03	1.14	0.49	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.14	1.22	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.44	0.76	0.25	1.01	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	0.95	0.00	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.97	1.33	1.03	0.88	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.03	1.72	1.08	1.29	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.48	2.83	0.73	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.18	1.08	0.62	1.86	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	32.58	0.90	0.30	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	27.99	1.71	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.67	1.81	0.08	0.86	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	24.66	1.91	1.01	0.70	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.49	0.91	0.46	2.28	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	33.21	1.21	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	39.21	3.44	0.53	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.42	2.13	0.53	0.93	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.17	1.25	0.88	1.00	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.53	0.25	2.28	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.31	2.11	1.51	1.51	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	28.43	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	28.83	0.93	1.40	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	22.21	0.00	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.01	1.57	0.00	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.76	1.47	1.18	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.65	2.67	0.25	0.67	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.04	1.40	0.47	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.56	1.73	0.14	1.44	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.54	3.57	0.51	0.76	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.83	2.07	0.38	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.16	1.40	0.42	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.30	0.59	0.34	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.19	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.92	1.96	0.24	1.22	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.96	1.99	1.10	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	27.50	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.99	1.17	0.39	0.97	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.92	0.53	0.79	1.85	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.76	2.23	1.49	0.37	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	1.80	1.44	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.97	2.27	0.85	2.56	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.02	2.76	1.18	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.16	0.76	0.76	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	31.95	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	32.60	2.51	2.09	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	37.59	0.46	1.38	0.46	0.00
Synoviocyte, donor1	11291-117A4	36.02	1.51	0.34	2.52	0.34
Synoviocyte, donor2	11368-117I9	38.89	1.51	0.67	0.84	0.34
Synoviocyte, donor3	11440-118H9	44.24	2.01	0.89	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	45.02	5.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.49	2.32	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	34.55	3.51	0.07	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	4.64	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	28.06	2.86	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.90	2.83	2.21	0.12	0.74
Urethra, donor2	10319-105A4	44.96	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	28.16	1.59	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	23.23	1.20	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	24.30	1.38	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	44.80	4.46	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	44.32	0.00	4.29	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.80	0.68	2.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.55	2.41	1.72	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	32.54	1.74	1.16	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	33.32	3.12	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	0.92	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	41.20	7.40	0.49	1.48	0.00
Wilms' tumor cell line:HFWT	10597-108E3	43.12	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.75	5.31	1.40	0.00	0.28
achilles tendon, donor2	10292-104G4	26.86	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	20.40	9.69	0.76	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.01	4.41	1.39	0.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	20.42	3.09	0.12	0.12	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	35.92	2.72	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	31.48	2.25	0.28	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	26.01	3.17	0.85	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	16.88	0.82	0.54	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.47	1.32	0.00	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.74	1.63	4.08	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.34	1.16	0.00	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	18.22	0.37	0.55	0.00	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	26.72	1.63	0.70	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	33.40	1.29	0.52	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.72	1.17	1.46	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.20	1.39	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	49.76	0.41	0.41	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.14	1.84	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.59	1.28	3.84	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	29.12	0.30	2.12	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.55	0.72	0.72	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.27	2.67	2.00	0.89	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.35	2.33	2.33	0.67	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	1.86	5.57	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.74	2.64	9.42	0.38	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	31.84	2.18	2.62	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	1.87	5.62	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	28.26	3.30	0.94	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	36.45	1.09	1.09	0.62	0.47
adipose, donor1	10184-103D4	29.32	1.17	0.00	0.00	0.00
adipose, donor2	10185-103D5	46.63	2.03	0.00	0.00	0.00
adipose, donor3	10186-103D6	34.85	3.27	0.27	0.00	0.54
adipose, donor4	10187-103D7	33.80	7.80	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	28.25	1.89	0.00	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	32.95	8.54	9.34	0.40	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	49.66	5.72	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	18.78	3.94	2.55	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	31.78	3.04	2.37	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	20.92	2.65	5.01	0.00	0.59
amygdala - adult, donor10196	10167-103B5	52.18	4.74	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	57.59	2.03	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	34.54	2.26	0.97	1.29	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	25.72	1.15	0.38	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	39.05	9.27	0.44	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	27.73	26.39	0.67	1.00	1.34
aorta, adult, pool1	10052-101G7	45.90	1.77	0.78	0.59	0.00
appendix, adult	10189-103D9	26.78	4.27	1.55	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	29.23	9.63	0.69	0.34	0.34
artery, adult	10190-103E1	32.61	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	50.70	4.20	0.00	0.14	0.14
b cell line:RPMI1788	10427-106D4	25.43	1.64	0.15	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	42.73	2.77	0.83	2.50	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	25.20	4.86	0.60	0.20	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	9.04	2.18	0.00	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	32.05	0.87	0.76	0.87	0.11
blood, adult, pool1	10053-101G8	15.50	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	59.09	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	33.07	1.35	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	68.68	0.00	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	52.23	0.45	0.67	0.56	0.00
brain, fetal, pool1	10085-102B4	42.74	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	8.59	2.31	0.99	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.82	12.11	7.11	0.25	1.25
breast, adult, donor1	10080-102A8	29.67	1.89	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.71	2.29	0.25	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.61	3.71	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.50	0.92	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.62	2.18	0.73	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	44.67	1.88	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	13.78	4.48	0.98	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	51.34	1.27	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	59.09	4.26	0.80	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	66.78	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	53.38	3.51	0.17	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	80.23	3.06	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	40.65	0.37	0.37	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	96.14	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	54.23	1.92	0.43	0.21	0.00
cerebellum, adult, pool1	10083-102B2	47.26	2.07	0.34	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	74.73	3.32	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	51.94	1.51	0.50	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	36.54	2.19	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	31.78	7.91	2.73	0.29	0.43
cervical cancer cell line:ME-180	10553-107I4	10.44	2.49	1.33	0.50	0.17
cervix, adult, pool1	10013-101C4	45.36	1.68	0.63	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.98	1.67	1.53	0.98	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	16.03	1.12	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	24.89	1.60	1.23	0.37	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	9.25	0.24	0.47	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	14.25	1.99	1.42	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	28.74	1.59	0.10	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	14.29	0.55	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	3.03	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.16	2.31	0.58	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	17.74	2.53	12.46	0.84	2.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	37.75	7.45	2.05	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	34.83	7.98	3.39	0.00	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.10	6.11	2.44	0.00	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	48.88	8.83	13.25	0.29	5.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	18.24	1.56	14.33	0.26	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	32.00	1.37	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	12.67	1.74	0.00	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	17.94	4.21	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	36.49	3.04	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	29.75	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	25.97	2.47	9.05	0.35	1.18
colon, fetal, donor1	10070-101I7	30.28	1.24	2.47	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	43.34	7.22	5.10	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	26.56	3.17	4.53	0.15	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	31.73	6.63	4.37	0.00	0.85
corpus callosum, adult, pool1	10042-101F6	90.11	1.66	1.77	1.00	0.66
cruciate ligament, donor2	10295-104G7	43.77	3.24	0.81	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	28.09	3.21	0.80	0.00	0.00
diencephalon, adult	10193-103E4	49.44	2.16	0.48	0.24	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.98	2.76	0.00	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.39	3.08	0.51	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.63	3.61	1.20	2.17	0.00
ductus deferens, adult	10196-103E7	30.40	5.98	1.99	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	8.64	5.76	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	34.58	2.21	7.36	0.00	2.94
dura mater, adult, donor1	10041-101F5	40.47	1.16	1.40	0.66	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.22	10.88	1.55	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.63	8.02	0.86	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	1.85	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	44.20	0.61	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.81	1.23	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	23.64	1.31	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	24.13	4.36	0.00	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	65.43	1.27	0.00	0.91	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.41	4.02	0.16	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	12.89	3.00	0.11	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.45	3.96	1.21	0.00	0.22
epididymis, adult	10197-103E8	38.72	2.09	2.72	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	62.98	2.31	1.60	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	30.67	2.75	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.84	5.77	1.97	0.26	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.73	6.20	2.95	0.30	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	16.13	4.71	2.46	0.22	2.02
esophagus, adult, pool1	10015-101C6	27.71	1.70	0.53	0.96	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.69	2.50	0.88	0.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	2.10	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	40.18	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	58.47	0.00	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	33.05	4.07	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	27.95	1.41	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.63	3.09	1.19	0.47	0.71
frontal lobe, adult, pool1	10040-101F4	57.23	1.13	0.75	0.38	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	22.82	1.80	2.10	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.53	0.82	0.09	0.00	0.09
gall bladder, adult	10198-103E9	30.66	1.93	1.21	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	50.46	4.29	2.68	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	33.99	2.24	3.36	0.00	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.79	3.80	0.84	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.40	5.22	0.19	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	55.42	2.62	0.16	0.66	0.33
gastric cancer cell line:GSS	10560-108A2	41.19	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	29.24	4.11	0.46	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	11.24	1.15	0.57	0.00	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	25.33	1.68	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.45	8.23	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	28.92	2.43	0.11	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.85	3.23	0.14	0.84	0.14
glioblastoma cell line:T98G	10485-107A8	30.90	2.43	0.44	0.22	0.11
glioma cell line:GI-1	10413-106B8	28.70	2.34	0.29	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	96.22	5.10	2.92	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	90.80	3.91	1.22	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	62.98	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	50.09	2.66	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	0.00	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	41.92	3.20	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	26.63	3.21	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	16.46	3.20	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	22.54	3.86	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	28.75	11.50	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	23.32	4.12	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	57.38	1.10	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	31.03	3.74	1.72	0.00	1.44
heart - mitral valve, adult	10205-103F7	31.99	0.90	2.09	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	23.53	1.05	1.31	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	16.65	0.83	0.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.20	1.84	0.82	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	40.03	3.41	1.28	1.70	0.00
heart, adult, pool1	10016-101C7	22.31	2.30	0.23	0.46	0.23
heart, fetal, pool1	10046-101G1	32.24	2.36	3.08	1.33	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	37.02	0.93	0.62	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	3.57	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	21.33	6.96	0.88	0.55	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.12	6.07	0.73	1.58	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	17.58	8.19	0.40	0.81	0.51
hepatoma cell line:Li-7	10484-107A7	26.36	4.23	0.44	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.86	8.14	0.60	0.40	0.40
hippocampus - adult, donor10196	10169-103B7	49.21	2.84	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	55.92	1.84	1.43	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	57.76	1.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	38.42	1.41	0.35	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	41.50	10.38	0.61	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	33.77	9.03	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.13	11.68	0.51	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.27	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	25.05	0.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.47	1.14	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	34.45	6.13	0.29	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	30.38	2.80	0.00	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	31.28	3.75	0.42	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	33.86	3.55	0.47	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.41	4.50	0.48	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.07	4.04	0.67	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.32	7.35	0.00	0.78	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.56	9.83	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	33.16	19.20	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.65	0.76	0.00	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.73	1.74	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	33.98	2.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.42	1.70	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.20	0.45	0.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	47.61	0.94	0.00	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.13	3.10	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.39	2.32	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	43.64	4.48	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	33.99	9.79	0.00	0.37	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	35.09	8.84	0.29	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	40.42	12.25	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.39	1.76	0.00	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	29.46	3.48	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.56	3.33	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.89	4.65	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	43.17	5.31	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.48	1.80	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.93	3.32	0.26	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	47.71	5.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.06	6.72	0.67	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	38.64	7.25	0.97	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	41.00	5.35	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.54	7.32	0.00	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.73	0.61	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.12	1.99	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.10	3.83	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	37.64	2.17	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.52	2.14	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	1.19	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	45.23	4.20	0.41	0.14	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.14	3.77	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	34.63	1.21	12.35	0.00	1.21
immature langerhans cells, donor2	11905-125F6	31.69	1.58	7.13	0.00	0.79
insula, adult, pool1	10039-101F3	69.18	1.61	1.04	0.57	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	10.40	0.65	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	34.64	5.41	0.30	0.50	0.40
kidney, fetal, pool1	10045-101F9	37.14	3.32	0.28	0.71	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	25.85	1.99	0.43	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.10	1.38	0.97	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.04	4.40	0.73	0.18	0.37
left atrium, adult, donor1	10079-102A7	24.52	1.09	0.00	1.09	0.00
left ventricle, adult, donor1	10078-102A6	26.29	2.02	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	48.16	14.77	0.55	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	27.66	2.16	2.87	3.95	0.00
leiomyoma cell line:15242A	10570-108B3	23.91	1.63	2.72	1.09	0.00
leiomyoma cell line:15425	10571-108B4	27.92	0.49	0.73	0.97	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	3.14	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	18.06	3.31	3.19	0.47	1.06
liposarcoma cell line:KMLS-1	10782-110G8	16.40	1.87	0.31	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	35.70	2.56	0.12	0.24	0.00
liver, adult, pool1	10018-101C9	16.53	3.08	2.27	0.16	0.49
liver, fetal, pool1	10086-102B5	11.29	0.00	1.88	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	59.64	4.67	0.58	0.73	0.15
locus coeruleus, adult, donor10252	10165-103B3	66.62	3.51	2.40	0.55	0.55
locus coeruleus, adult, donor10258	10375-105G6	75.90	3.67	1.69	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	22.71	1.68	1.68	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.78	1.66	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	17.24	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.75	1.98	0.13	0.00	0.00
lung, adult, pool1	10019-101D1	36.74	2.95	1.89	1.06	0.71
lung, fetal, donor1	10068-101I5	62.22	2.57	2.85	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	39.86	7.33	4.58	1.37	0.46
lymph node, adult, donor1	10077-102A5	26.51	2.84	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	14.68	3.51	0.88	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.90	11.92	0.45	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	16.14	7.65	0.85	0.85	1.70
mature adipocyte, donor1	12231-129F8	50.61	0.00	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	45.24	2.49	0.62	1.25	0.00
mature adipocyte, donor3	12233-129G1	44.80	0.24	0.71	1.66	0.24
mature adipocyte, donor4	12234-129G2	58.17	1.32	0.00	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	23.83	3.57	0.71	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	71.07	1.13	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	52.97	1.29	0.74	0.00	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	58.14	1.59	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	27.72	1.28	0.43	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	59.40	1.52	0.34	0.84	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	52.00	0.85	0.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	100.17	5.78	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	38.41	1.08	0.72	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	72.69	4.54	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	66.88	4.18	1.08	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	64.89	3.18	1.63	1.31	0.49
medulla oblongata, newborn, donor10223	10361-105F1	48.95	1.39	0.00	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	31.00	2.21	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	23.72	5.87	0.24	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	36.22	4.89	2.30	0.29	1.58
melanoma cell line:G-361	10465-106H6	32.58	2.17	2.99	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	25.15	1.27	0.54	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	75.78	12.34	2.64	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	60.66	5.18	0.26	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.36	1.07	0.61	1.38	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.90	0.55	0.55	1.45	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	31.47	0.83	1.24	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.50	1.26	1.12	0.14	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	27.34	1.54	1.16	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	30.54	0.69	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	25.23	1.03	1.37	0.17	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.38	1.27	2.07	0.35	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	32.89	1.06	1.19	1.06	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	28.49	2.30	1.08	1.22	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.44	2.13	0.71	0.57	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.34	0.00	1.98	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	30.72	1.80	0.42	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.21	1.40	0.00	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.75	1.02	1.22	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	24.80	1.08	0.72	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.00	0.62	0.93	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.15	1.14	0.91	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.89	2.52	0.84	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.76	0.90	0.45	1.64	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	36.06	1.93	0.79	0.35	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	39.02	1.84	0.74	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.04	1.14	0.29	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.10	2.95	1.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.86	2.28	0.91	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	23.53	0.26	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.36	1.57	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	27.73	0.62	1.23	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.83	0.47	0.47	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.46	0.68	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	32.62	1.18	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.27	0.93	0.46	1.39	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.61	1.44	0.29	0.87	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.56	0.89	0.22	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.77	0.96	0.48	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	0.00	2.20	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	26.18	1.34	1.01	1.01	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	28.66	1.23	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.77	0.43	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	57.42	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	30.21	1.62	0.97	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	40.51	2.13	1.07	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	32.71	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	36.15	1.17	1.17	1.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	0.99	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.06	1.19	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.94	1.27	0.00	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.49	1.38	1.72	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.19	0.81	1.22	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.16	3.18	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.12	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.12	0.62	0.94	1.56	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	0.00	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.98	2.07	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	37.11	3.96	0.99	2.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	40.07	1.91	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	32.24	2.42	0.81	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	0.00	1.27	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	35.20	3.64	0.61	2.43	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	49.42	3.29	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.53	1.19	0.60	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.69	0.65	1.62	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	1.02	0.00	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	42.55	1.55	0.00	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.68	1.89	0.47	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	10.43	0.70	0.00	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.11	3.49	0.41	0.41	0.00
mesothelioma cell line:Mero-25	10850-111F4	17.48	2.27	0.45	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	22.49	2.69	0.73	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	34.76	3.32	0.66	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	28.91	6.04	0.79	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	44.94	5.62	0.34	1.02	0.34
mesothelioma cell line:Mero-84	10855-111F9	16.43	1.77	0.51	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.30	3.73	1.24	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	26.17	3.31	0.83	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	32.76	6.52	1.09	1.27	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	1.88	0.68	0.51	0.00
mesothelioma cell line:NCI-H28	10845-111E8	49.11	6.87	1.02	1.78	0.76
mesothelioma cell line:No36	10857-111G2	31.64	2.28	0.65	0.65	0.98
mesothelioma cell line:ONE58	10858-111G3	25.47	2.71	0.54	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	36.08	2.11	1.34	0.19	0.58
migratory langerhans cells, donor2	11902-125F3	37.25	1.10	0.24	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	46.66	2.33	0.36	0.00	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.95	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.51	3.18	0.21	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.04	3.46	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	35.97	3.62	3.81	0.38	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	36.77	1.66	0.37	0.18	0.00
myeloma cell line:PCM6	10474-106I6	34.79	4.55	1.58	0.40	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	36.52	4.06	1.52	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.97	1.57	0.59	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	22.28	2.34	1.00	0.00	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.30	2.65	1.62	0.07	0.74
nasal epithelial cells, donor2	12227-129F4	33.67	3.86	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	58.44	2.76	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	60.62	4.12	0.37	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	19.19	1.27	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	40.07	2.05	0.37	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	28.70	0.71	0.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	33.42	1.58	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	28.98	3.82	0.40	0.60	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	34.33	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	35.40	2.66	0.80	0.80	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.30	2.03	0.51	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	24.02	8.81	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	32.38	1.60	1.28	0.96	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.93	2.36	0.00	2.89	0.79
nucleus accumbens, adult, pool1	10037-101F1	59.24	1.41	0.66	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	57.69	2.06	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	57.43	2.42	0.54	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	40.40	1.09	0.00	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	64.03	2.10	1.31	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	90.97	2.15	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	49.67	0.95	0.55	0.71	0.16
olfactory region, adult	10195-103E6	50.63	2.10	0.38	0.00	0.00
optic nerve, donor1	10277-104E7	120.06	6.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	23.24	4.56	0.34	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	31.46	2.61	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.47	3.39	0.34	0.00	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	12.59	5.43	0.69	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	36.75	2.35	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	39.24	4.67	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	26.30	1.70	0.21	1.48	0.00
ovary, adult, pool1	10020-101D2	36.60	1.14	0.52	0.00	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.62	0.37	0.37	0.00	0.37
pancreas, adult, donor1	10049-101G4	32.92	10.35	2.82	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	1.96	1.12	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	44.80	4.09	1.36	0.34	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.71	2.81	0.17	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	60.50	1.10	1.01	0.55	0.18
parietal cortex, adult, donor10258	10373-105G4	38.90	0.00	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	59.25	0.94	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	54.44	2.00	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	59.57	1.41	1.32	0.70	0.18
parietal lobe, fetal, donor1	10072-101I9	97.95	2.91	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	36.26	1.87	0.37	0.75	0.37
parotid gland, adult	10199-103F1	36.38	3.08	1.23	0.62	0.00
penis, adult	10200-103F2	36.52	0.54	1.07	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.63	1.12	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.56	3.06	0.29	0.58	0.15
pineal gland - adult, donor10196	10179-103C8	30.32	7.10	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	47.97	7.70	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	49.54	1.25	0.63	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	58.68	12.14	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	87.04	9.90	1.04	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	61.29	7.66	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	23.76	1.40	1.29	0.32	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	11.65	2.25	0.13	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.39	2.33	0.16	0.31	0.16
pons, adult, pool1	10033-101E6	57.67	2.07	0.86	0.09	0.26
postcentral gyrus, adult, pool1	10032-101E5	60.50	1.13	1.13	0.70	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	4.18	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	43.55	3.35	0.15	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	61.35	8.89	0.36	0.73	0.18
prostate, adult, pool1	10022-101D4	36.82	4.17	0.27	0.54	0.27
putamen, adult, donor10196	10176-103C5	63.03	1.89	0.00	0.71	0.00
putamen, adult, donor10252	10152-102I8	76.47	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	2.19	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	44.94	0.97	0.48	0.24	0.24
putamen, newborn, donor10223	10365-105F5	18.74	2.25	3.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	8.15	2.33	0.29	0.00	0.29
rectum, fetal, donor1	10067-101I4	44.51	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.44	0.85	0.42	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	55.56	4.57	3.78	0.89	1.19
retinoblastoma cell line:Y79	10475-106I7	38.71	7.27	0.26	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	39.84	6.39	0.00	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	35.71	2.25	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	17.32	4.53	0.97	0.00	0.32
salivary acinar cells, donor2	11772-123I8	19.00	6.20	3.17	1.38	0.69
salivary acinar cells, donor3	11773-123I9	23.17	5.96	1.99	1.32	2.65
salivary gland, adult, pool1	10093-102C3	54.34	4.58	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	56.57	1.35	1.43	0.08	1.60
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	54.07	2.47	2.70	0.35	0.59
seminal vesicle, adult	10201-103F3	35.45	3.70	1.59	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.89	1.70	3.16	0.49	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.44	0.75	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.87	2.55	0.13	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	18.24	3.54	1.11	0.00	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.68	1.42	1.68	0.13	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	21.99	0.71	0.00	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	19.67	1.20	0.12	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	21.11	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	37.87	3.16	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.03	7.00	1.33	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	72.50	11.98	2.21	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	44.52	1.16	0.00	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	23.24	5.27	0.33	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.14	2.09	0.16	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	39.88	11.11	0.44	0.22	0.44
small intestine, adult, pool1	10024-101D6	20.07	5.26	29.14	0.48	5.73
small intestine, fetal, donor1	10064-101I1	22.11	2.70	12.53	0.74	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.16	4.10	1.03	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	31.01	0.78	1.29	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	16.08	6.16	0.54	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	81.21	3.21	2.06	0.92	0.69
spinal cord, adult, donor10252	10159-103A6	83.19	1.97	0.79	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	65.72	3.46	2.77	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	72.57	2.44	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	59.70	0.92	2.76	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	32.71	2.24	0.30	0.90	0.30
spleen, adult, pool1	10025-101D7	27.09	1.54	0.00	0.33	0.00
spleen, fetal, pool1	10044-101F8	26.14	1.27	1.35	0.40	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.77	2.07	0.62	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.11	2.09	0.19	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.86	2.45	2.10	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.63	7.43	1.17	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.06	6.64	1.01	0.34	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.10	3.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.46	1.27	0.85	0.85	0.00
stomach, fetal, donor1	10062-101H8	40.58	9.61	6.41	0.00	0.00
submaxillary gland, adult	10202-103F4	29.62	3.99	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	83.08	3.32	2.28	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	47.07	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	53.70	1.41	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	40.12	1.38	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	57.47	1.44	0.42	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	95.44	3.56	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	67.25	1.32	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	39.10	0.35	0.00	1.40	0.00
tenocyte, donor2	11765-123I1	52.65	1.53	0.76	0.76	0.00
tenocyte, donor3	11768-123I4	38.18	0.74	0.74	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.74	4.93	0.17	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	36.38	5.24	0.46	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	32.39	2.48	0.62	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.38	3.68	0.51	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	1.51	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.09	0.65	0.98	0.11	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.54	2.93	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	56.16	2.25	1.18	1.29	0.11
testis, adult, pool2	10096-102C6	97.89	7.22	1.80	1.35	0.90
thalamus - adult, donor10196	10168-103B6	97.15	6.62	2.21	2.21	1.10
thalamus, adult, donor10252	10154-103A1	66.73	2.34	1.56	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	143.18	3.08	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	71.80	1.81	0.82	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	14.96	1.15	0.58	0.58	0.58
throat, adult	10209-103G2	28.96	0.50	1.25	0.25	0.00
throat, fetal, donor1	10061-101H7	36.26	4.57	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	58.82	3.18	0.00	0.79	0.20
thymus, adult, pool1	10027-101D9	29.73	2.88	0.00	0.40	0.10
thymus, fetal, pool1	10043-101F7	30.96	3.84	0.73	0.31	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	30.98	3.06	0.66	0.00	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	39.53	2.51	0.42	0.00	0.28
thyroid, adult, pool1	10028-101E1	34.53	5.13	0.65	0.75	0.09
thyroid, fetal, donor1	10060-101H6	40.87	5.01	0.53	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	19.30	0.70	1.40	0.23	0.23
tongue, fetal, donor1	10059-101H5	31.53	2.76	0.00	0.00	0.79
tonsil, adult, pool1	10047-101G2	27.95	2.91	0.70	0.20	0.30
trachea, adult, pool1	10029-101E2	26.50	2.29	0.74	0.16	0.41
trachea, fetal, donor1	10058-101H4	34.62	2.31	1.15	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.93	1.42	1.42	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	18.34	4.05	0.10	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	46.69	2.66	1.25	0.00	0.94
tridermal teratoma cell line:HGRT	10694-109G1	24.73	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.10	3.30	0.59	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	25.04	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	66.72	0.68	1.54	1.37	0.00
uterus, fetal, donor1	10055-101H1	57.34	2.05	0.00	0.00	0.00
vagina, adult	10204-103F6	20.03	1.94	0.65	0.65	0.00
vein, adult	10191-103E2	31.56	1.97	0.88	0.00	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.02	1.87	0.27	0.27	0.00